Bettina Debu

Prof. Bettina Debu

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2018 in Current Neurology and Neuroscience Reports
Verified
Journal Article
Closed access
PDF file
BDBettina Debu
Bettina Debu
CGClecio De Oliveira Godeiro
Clecio De Oliveira Godeiro
JLJarbas Correa Lino
Jarbas Correa Lino
EMElena Moro
Elena Moro

27 February 2013 in European Neurology
Verified
Journal Article
Open access
PDF file
MFM.U. Ferraye
M.U. Ferraye
CAC. Ardouin
C. Ardouin
ELE. Lhommée
E. Lhommée
VFV. Fraix
V. Fraix
PKP. Krack
P. Krack
BDBettina Debu
Bettina Debu
We examined executive functioning in patients with Parkinson's disease exhibiting, or not, levodopa-resistant freezing of gait (L-FOG). 38 advanced-stage patients with L-FOG were identified in a consecutive series of 400 patients. They were matched with 38 patients without L-FOG. All patients underwent prospective evaluations of cognitive and motor functioning before subthalamic nucleus surgery, and 1 year after. A composite frontal score, a measure of executive functioning, was compared between the two groups. We also examined correlations between the frontal score and the score on the FOG item of the Unified Parkinson Disease Rating Scale II. Results show that after surgery, patients with L-FOG, as a group, were more impaired in executive functioning than control patients. However, individual data analysis showed preserved executive functions in 11 patients with L-FOG. In addition, there was no correlation between L-FOG severity and the degree of executive impairment. Therefore, frontal dysfunction may be one mechanism underlying L-FOG in a number of patients with Parkinson's disease. However, since some patients develop L-FOG despite the preservation of executive functions, lesions or dysfunction of other neuronal structures are likely to be involved.


26 October 2024 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
MMMari Muldmaa
Mari Muldmaa
ESEmmanuelle Schmitt
Emmanuelle Schmitt
RIRoberto Infante
Roberto Infante
AKAndrea Kistner
Andrea Kistner
VFValérie Fraix
Valérie Fraix
EMElena Moro
Elena Moro
The impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on neuropsychiatric fluctuations in Parkinson´s disease (PD) remains unclear. The Neuropsychiatric Fluctuations Scale (NFS) can help to fill this gap, directly measuring fluctuations between the OFF- and ON-medication conditions. The NFS provides NFS-plus (hyperdopaminergic) and NFS-minus (hypodopaminergic) sub-scores. Based on these, the NFS global scores express the overall magnitude of neuropsychiatric symptoms in both the OFF- and ON-medication states. The total fluctuation score (TFS) represents the difference between ON- vs. OFF-medication NFS global scores, thus assessing fluctuations amplitude. The NFS was used to evaluate changes in neuropsychiatric fluctuations between the OFF- and ON-medication conditions before and 1-year after bilateral STN-DBS in 45 PD patients (32 males; mean age, 61.3 ± 7.2 years; PD duration, 10.2 ± 3.0 years). After surgery, the amplitude of neuropsychiatric fluctuations was significantly reduced (p < 0.001), confirming the efficacy of STN-DBS on these symptoms.

15 July 2025 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
ESEmmanuelle Schmitt
Emmanuelle Schmitt
MBMartine Bouvard
Martine Bouvard
MAMathieu Anheim
Mathieu Anheim
DGDominique Guehl
Dominique Guehl
HKHelene Klinger
Helene Klinger
EMElena Moro
Elena Moro
Neuropsychiatric fluctuations (NpsyF) are common in advanced Parkinson's disease patients (PD). In the OFF-medication condition, they manifest as minus symptoms such as anxiety and fatigue, while in the ON-medication condition, plus symptoms like euphoria appear. These fluctuations significantly impact the quality of life for patients and caregivers, making their identification crucial for effective PD management. The Neuropsychiatric Fluctuation Scale (NFS) was developed to assess NpsyF in real time, and a recent study indicated that the NFS has good psychometric properties. To evaluate and confirm the psychometric characteristics of the NFS in a prospective multicenter study (NFS-VALID). The NFS was administered to PD patients with motor fluctuations in both ON and OFF-medication conditions, alongside other assessment scales, including motor scale and evaluations of emotional and behavioral aspects. Internal structure was evaluated using principal component analysis (PCA), and internal consistency was assessed with Cronbach's alpha. External validity was measured through correlations with other scales. Specificity was assessed by comparing NFS scores between controls and PD patients, as well as between PD patients with and without NpsyF. Sensitivity was evaluated using t-tests comparing NFS in ON and OFF conditions. 128 PD patients and 131controls were included. PCA revealed two components with a main one explaining 35-42 % of the variance. Internal consistency was good (alpha >.85 in ON and OFF). The NFS showed good specificity and sensitivity. This study confirms that the NFS is a reliable tool to evaluate NpsyF in PD patients in an acute setting.

1 November 2020 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
DPDominic Pérennou
Dominic Pérennou
MJMarie Jaeger
Marie Jaeger
BDBettina Debu
Bettina Debu
VFValérie Fraix
Valérie Fraix
AMAdelaide Marquer
Adelaide Marquer
ACAnna Castrioto
Anna Castrioto